PIPages
Labs

Hugh Taylor

Yale University, CT·Medicine & Clinical Research

Fibroids are benign tumors of the uterine muscle wall and the most common neoplastic threat to women's health worldwide. They fall disproportionately on women of color and are a significant cause of infertility, since intramural and submucosal fibroids lower the chance of pregnancy.

Fields

Medicine & Clinical Research

Pharmacology

Topics

uterine fibroids

leiomyoma

infertility

Grants
1 known grant, last ended Aug 2026

What they work on

  1. Test whether oral EGCG, a catechin from green tea leaves, reduces uterine fibroid size compared with matched placebo in a randomized trial of 654 women seeking fertility care.
  2. Compare pregnancy and live birth outcomes between EGCG and placebo arms following a three-month run-in and up to four cycles of ovarian stimulation with intrauterine insemination.
  3. Operate the data coordinating center and a clinical recruitment site at Yale within the four-institution consortium assembled to reach enrollment targets.

More about the research

Surgical removal recurs often and can leave adhesions, internal scar tissue that itself impairs fertility, so there is a real need for treatments that are neither hormonal nor surgical and that are safe for women actively trying to conceive.

Why it matters

For women whose fibroids are the only abnormality found after full infertility evaluation, and for the many women of color disproportionately affected, a tolerable oral agent taken during fertility treatment would be an alternative to surgery with its recurrence and adhesion risks. If the trial shows benefit, EGCG could become a low-cost, fertility-compatible option for improving pregnancy and live birth rates.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4

NIH · Sep 2019 – Aug 2026

Closest labs

Thomas G Boyer

University of Texas Health Science Center at San Antonio, TX·Biochemistry

Determine how fibroid-causing MED12 mutations destabilize the T-loop of the CDK8 enzyme and reduce its substrate binding and activity, using structural biology and biochemistry.

Ganesa Wegienka

University of Michigan, MI·Public Health & Epidemiology

Assess how repeated self-reported stress and adverse life events over 10 years relate to uterine fibroid onset and growth measured by ultrasound in the SELF cohort of young Black women in Detroit.

Brittney Browning

Medical University of South Carolina, SC·Medicine & Clinical Research·Early-career

Test whether six weeks of 125 mg/day oleoylethanolamide (OEA), an endocannabinoid-like lipid, lowers peripheral inflammation markers IL-6, TNF-alpha, IL-1beta and the bacterial molecule LPS in young adults with alcohol use disorder.

The school

Yale University: 73 labs on PI Pages, $1.5B a year on research, 438 research doctorates a year.

More about Yale University

Reach out

A start for your email. Fill in the brackets.